چاپ صفحه |  صفحه نخست سامانه |  نویسندگان |  اطلاعات تفضیلی |  دانلود مقاله | دانشگاه علوم پزشکی تبریز |
| نویسنده ثبت کننده مقاله | فرزاد نجفی پور |
| مرحله جاری مقاله | تایید نهایی |
| دانشکده/مرکز مربوطه | مرکز تحقیقات غدد درون ریز |
| کد مقاله | 83684 |
| عنوان فارسی مقاله | An Overview of the Diagnosis, Treatment, and Follow-up of Acromegaly: A consensus review |
| عنوان لاتین مقاله | An Overview of the Diagnosis, Treatment, and Follow-up of Acromegaly: A consensus review |
| نوع ارائه | پوستر |
| عنوان کنگره / همایش | چهاردهمین کنگره بین المللی بیماری های غدد درون ریز و متابولیسم |
| نوع کنگره / همایش | بین المللی |
| کشور محل برگزاری کنگره/ همایش | Iran (Islamic Republic) |
| شهر محل برگزاری کنگره/ همایش | تهران |
| سال انتشار/ ارائه شمسی | 1402 |
| سال انتشار/ارائه میلادی | 2023 |
| تاریخ شمسی شروع و خاتمه کنگره/همایش | 1402/09/01 الی 1402/09/03 |
| آدرس لینک مقاله/ همایش در شبکه اینترنت | http://14iced2023.ir/enindex.php |
| آدرس علمی (Affiliation) نویسنده متقاضی | Endocrine research center, Tabriz university of medical sciences |
| نویسنده | نفر چندم مقاله |
|---|---|
| حلیمه امیرآزاد | اول |
| فرزاد نجفی پور | سوم |
| نعیمه مصری علمداری | چهارم |
| سمیرا پورمرادیان | پنجم |
| مصطفی نجفی پور | دوم |
| عنوان | متن |
|---|---|
| خلاصه مقاله | Acromegaly is a rare and heterogeneous disorder, often caused by a growth hormone-secreting pituitary adenoma. Despite the availability of three treatment modalities (surgery, medical treatment, and radiotherapy), and the approval of new drugs in recent decades, some patients continue to experience active disease despite undergoing treatment. Hence, there is a demand for innovative therapies in the management of acromegaly, which involves the exploration of new formulations for existing drugs and the development of entirely new drugs currently undergoing research. The purpose of this article is to provide an up-to-date review on the diagnosis, treatment, follow-up and genetic screening of acromegaly. The utilization of modern technology in transsphenoidal microsurgery has resulted in modest improvements in outcomes while expanding the range of treatable conditions and enhancing patient safety during procedures. Advancements in drug formulations have substantially enhanced the effectiveness of treatment for acromegaly, particularly with the development of extended-release formulations and novel drugs. The ongoing progress in somatostatin receptor ligands (SRLs) is expanding treatment options, offering promising avenues for potential new therapies in future clinical practice. Furthermore, identifying genetic mutations enables the targeted screening for associated health issues and establishes the condition within family members prior to the onset of clinical symptoms. |
| کلمات کلیدی | Acromegaly, IGF-1, Pituitary Surgery, Radiotherapy, Somatostatin Analogues |
| نام فایل | تاریخ درج فایل | اندازه فایل | دانلود |
|---|---|---|---|
| poster-ppt acromegaly.pdf | 1402/11/03 | 254406 | دانلود |
| The 14TH International Congress of Endocrine Disorders .pdf | 1402/10/13 | 260247 | دانلود |
